Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CardioFocus logo — Lesion Creation at the Speed of Light

CardioFocus

Lesion Creation at the Speed of Light

Founded 1990 65 employees Venture round Total: $205.30M Biotechnology, Health Care +2

General Information

Company Name CardioFocus
Founded Year 1990
Founders / Decision Makers
Team member Team member
Employees 65
Industries Biotechnology, Health Care, Medical Devices +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CardioFocus. To contact CardioFocus, visit cardiofocus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CardioFocus compare?

A PDF of CardioFocus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CardioFocus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CardioFocus

CardioFocus is a pioneering medical device company specialized in advancing ablation treatment for cardiac disorders, particularly atrial fibrillation (AFib). Its FDA-approved HeartLight Endoscopic Ablation System has effectively treated over 10,000 patients globally with its revolutionary catheter ablation technology, which offers direct visualization and titratable laser energy. The system has become a new standard for AFib ablation. Established in 1990 and headquartered in Marlborough, MA, CardioFocus operates within the industries of Biotechnology, Healthcare, Medical Devices, and Pharmaceuticals. The company's recent Debt Financing investment on February 23, 2023 underscores investor confidence in its innovative approach to improving cardiac care. While the specific investors involved in this round are not disclosed, the investment signifies ongoing support and belief in CardioFocus' mission. With its impactful slogan "Lesion Creation at the Speed of Light," CardioFocus continues to drive advancements in cardiac health and stands as a notable player in the medical technology landscape. For more details, interested parties can visit www.CardioFocus.com.

Business keywords: Ablation Treatment, Cardiac Disorders, Atrial Fibrillation, Electrophysiology, Innovative Technology, Catheter Ablation, Fiber Optic Catheters, Cardiac Arrhythmias, FDA-approved, Healthcare Innovation, Clinical Treatment, Medical Innovations, Cardiology

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $27.16M -
23 Feb 2023
Debt Financing Undisclosed -
23 Feb 2023
Venture Round $4.00M -
12 Apr 2022
Venture Round $12.02M -
07 Jul 2020
Venture Round $55.00M 1
Kennedy Lewis Investment Management
29 May 2019
Debt Financing $21.00M -
22 Jun 2018
Venture Round $20.18M -
01 Mar 2017
Debt Financing Undisclosed 1
SV Health Investors
SV Health Investors
28 Sep 2016
Venture Round $32.00M -
07 Jan 2015
Debt Financing $5.00M 1
Silicon Valley Bank
21 Mar 2011

View All 15 Funding Rounds

CardioFocus Alternatives & Competitors

View All Alternatives
CardioFocus vs
Ablation Frontiers
Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF techno...

Series C
Biopharma, Biotechnology
Compare CardioFocus vs Ablation Frontiers
CardioFocus vs
Biosense Webster
Biosense Webster United States

Discover a New Possible

3404 employees
Biotechnology, Health Care
Compare CardioFocus vs Biosense Webster
CardioFocus vs
Adagio Medical Inc.
Adagio Medical Inc. United States

Sponsor of FDA approved IDE iCLAS Clinical Study for patients with Persistent Atrial Fibrillation. N...

Debt Financing
66 employees
Health Care, Pharmaceutical
Compare CardioFocus vs Adagio Medical Inc.
Also compare with: CardioFocus vs S4 Medical S4 Medical CardioFocus vs Volta Medical Volta Medical CardioFocus vs Acutus Medical, Inc. Acutus Medical, Inc. View all alternatives

FAQ About CardioFocus

Lesion Creation at the Speed of Light
CardioFocus was founded in 1990.
CardioFocus operates in Biotechnology, Health Care, Medical Devices and Pharmaceutical. Its work centres on Ablation Treatment, Cardiac Disorders, Atrial Fibrillation and Electrophysiology.
CardioFocus has approximately 65 employees.
CardioFocus has completed 15 funding rounds, raising a total of $205.30M. The latest funding stage is Venture round.
Top alternatives and competitors to CardioFocus include Ablation Frontiers, Biosense Webster, Adagio Medical Inc., CoreMap, S4 Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardioFocus and Ablation Frontiers are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CardioFocus, https://bouncewatch.com/company/cardiofocus, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes